Excagol targets the global blood collection market. According to Grand View Research, the blood collection market reached USD 8.5 Billion in 2018 and is projected to reach USD 13.99 Billion by 2026, growing at a CAGR of 6.6%. Excagol targets the venipuncture product market which is projected to reach over USD 962.7 Million by 2026, growing at a CAGR of 3.2% from 2021 to 2026.